Orchestra BioMed Holdings, Inc. - Ordinary Shares — Cash Flow (NASDAQ:OBIO) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities —-272.36 K-1.58 M-46.13 M-50.56 M-48.96 M -54.52 M Cash from investing activities —092.59 M10.69 M13.09 M-26.94 M -29.62 M Cash from financing activities —0-92.59 M46.22 M29.17 M88.33 M 94.16 M Free cash flow —-272.36 K-1.58 M-46.13 M-50.56 M-49.45 M -55.08 M

News

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates

Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates

NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates

Chardan reiterates Orchestra BioMed stock rating on trial focus

Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates

Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates

Orchestra BioMed to present hypertension therapy data at medical meetings

TD Cowen initiates Orchestra BioMed stock with Buy rating on novel medical device portfolio

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Beats Revenue Estimates

ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?